Skip to Main Content

Dubai Health Authority - هيئة الصحة دبي

Text Resize

Use the buttons below to increase or decrease the text size

Contrast switch

Use the toggle below to switch the contrast.

SCREEN READER

Listen to the content of the page by clicking play on ReadSpeaker.

Access

To discover more about accessibility, view our Accessibility Options here

Dubai Health Authority - هيئة الصحة دبي

Text Resize

Use the buttons below to increase or decrease the text size

Contrast switch

Use the toggle below to switch the contrast.

SCREEN READER

Listen to the content of the page by clicking play on ReadSpeaker.

Access

To discover more about accessibility, view our Accessibility Options here

Circular No. (30\2026) Voluntary Recall of Two Batches of ZOPIJUB (Zopiclone Tablets 7.5 mg)

15 Jul 2026

Reference: CIR-2026-00000099


 

To all Health facilities and healthcare practitioners in Dubai's private health sector

 

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the Emirates Drug Establishment for perusal and adherence to what is stated.

 

Circular No. (29/2026) Voluntary Recall of Two Batches of ZOPIJUB (Zopiclone Tablets 7.5 mg)

 

Thanks in advance for your good co-operation

 

 Drug Control Section

Supporting Documents:

icon

ZOPIJUB (Zopiclone Tablets 7.5 mg).pdf

icondownload

Do you find this Content helpful?

Close